BioCentury
ARTICLE | Company News

Trimel submits NDA for CompleoTRT

May 1, 2013 12:39 AM UTC

Trimel Pharmaceuticals Corp. (TSX:TRL) submitted an NDA to FDA for CompleoTRT to treat testosterone deficiency in men. The product is a bioadhesive intranasal gel formulation of testosterone. Trimel w...